Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Generic drugFirst approved 2021

Lenalidomide

Medicare prescription drug cost, prescriptions and prescribers, 2024

$2.64B

Medicare cost, 2024

Medicare drug plans spent $2.6 billion on Lenalidomide in 2024, for 197,995 prescriptions and refills filled by 30,339 patients. It ranks 17th among all drugs by Medicare drug plan spending. Spending rose 57% from 2023 to 2024. It was first approved in 2021.

Medicare cost, 2024

$2.64B

+57.1% from 2023

Prescriptions

198K

$13,334.05 per claim

Patients

30K

10,560 prescribers

Total spending, 2024

$2.64B

$87,001.87 per patient

Questions and answers

How much does Medicare spend on Lenalidomide?

Medicare prescription drug plans paid $2.64B for Lenalidomide in 2024, for 197,995 prescriptions and refills to 30,339 patients (up 57.1% from 2023). The average cost per claim was $13,334.05.

Which state spends the most on Lenalidomide?

California had the highest Medicare cost for Lenalidomide in 2024: $318.9M for 25,305 claims, followed by New York ($226.8M).

Who prescribes Lenalidomide the most?

Emerentia A Agyemang, nurse practitioner in Boston, MA, had the highest Medicare cost for Lenalidomide in 2024: 537 claims costing $6.5M.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Lenalidomide was $2.64B in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Lenalidomide, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Emerentia A Agyemang Boston, MANurse Practitioner53785$6.5M
Jennifer E Miller Rochester, NYNurse Practitioner36677$5.7M
Gina B Fries Rochester, NYPhysician Assistant36173$5.2M
Ami P Ndiaye Charlotte, NCNurse Practitioner35588$5.0M
Rachid C Baz Tampa, FLHematology-Oncology34071$4.8M
Ian T Lund Buffalo, NYPhysician Assistant28594$4.7M
Andrew P Dalovisio Baton Rouge, LAHematology-Oncology31460$4.6M
Katie Jones New York, NYNurse Practitioner31280$4.5M
Larry D Anderson Jr. Dallas, TXHematopoietic Cell Transplantation and Cellular Therapy36049$4.4M
Ferdinand D Dayalo South El Monte, CANurse Practitioner36651$4.4M
Michael M Green Baltimore, MDHematology-Oncology35946$4.3M
Sascha A Tuchman Durham, NCHematopoietic Cell Transplantation and Cellular Therapy27939$4.2M
Kristina M Slemmer Buffalo, NYPhysician Assistant25188$4.2M
Jordan D Robinson Charlotte, NCPhysician Assistant29180$4.1M
Kenneth S Poon San Leandro, CAHematology-Oncology34135$3.7M
Kevin Brigle Richmond, VANurse Practitioner26137$3.5M
Hailey Battaglia Knight Chicago, ILPhysician Assistant21793$3.5M
Jill N Burke Boston, MANurse Practitioner25232$3.4M
Brandon J Blue Tampa, FLHematology-Oncology24050$3.4M
Craig C Hofmeister Atlanta, GAHematology24038$3.3M
Susan Y Kao Berkeley, CAInternal Medicine24528$3.2M
Sendhilnathan Ramalingam Durham, NCHematology-Oncology24439$3.2M
Al-Ola A Abdallah Tulsa, OKHematology23450$3.2M
Nisha S Joseph Atlanta, GAMedical Oncology22329$3.1M
Michael Toole Fort Wayne, INHematology-Oncology21132$3.1M

Prescriber data by year

YearPrescribersClaimsPatientsCost
20225,31532,3019,847$448.2M
20238,741121,72220,385$1.68B
202410,560197,99530,339$2.64B

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Teva PharmTEVA logoTEVA66,919$876.3M
Dr.Reddy'S LabRDY logoRDY37,825$503.6M
Alvogen Inc25,519$354.5M
Apotex Corp21,196$289.9M
Cipla USA, Inc.CIPLA.NS logoCIPLA.NS9,628$129.5M
Zydus PharmaceuZYDUSLIFE.NS logoZYDUSLIFE.NS8,247$115.3M
Sun PharmaceutiSUNPHARMA.NS logoSUNPHARMA.NS8,414$108.8M
MylanVTRS logoVTRS9,027$107.1M
Camber Pharmace6,536$90.8M
Aurobindo PharmAUROPHARMA.NS logoAUROPHARMA.NS4,756$64.9M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
180
RxNorm concept IDs
1242231, 1428947, 602910, 602912, 643712
Application numbers
ANDA201452, ANDA209348, ANDA210154, ANDA210435, ANDA210480

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube